Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lundell

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Cancer|January 1, 1997
Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinomaA Taube, G Lundell
Lakartidningen|September 19, 1973
[A new system of dose-portion administration of drugs]G Lundell, L Nilsson
Acta Radiologica. Oncology|January 1, 1980
Hypothyroidism following 131I therapy for hyperthyroidism in relation to immunologic parametersG Lundell, L E Holm
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1989
Swedish thyroid cancer risk from Chernobyl?L E Holm, G Lundell
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|January 22, 2005
Anaplastic giant cell thyroid carcinomaG Wallin, G Lundell, J Tennvall
Acta Endocrinologica|August 1, 1993
Graves' ophthalmopathy and tobacco smokingL Tallstedt, G Lundell, A Taube
Acta Radiologica: Therapy, Physics, Biology|May 1, 1977
75Se-Selenite scrintigraphy in the clinical staging of malignant lymphomasD Killander, D Lindblom, G Lundell
Journal of the National Cancer Institute|December 1, 1980
Incidence of malignant thyroid tumors in humans after exposure to diagnostic doses of iodine-131. II. Estimation of thyroid gland size, thyroid radiation dose, and predicted versus observed number of malignant thyroid tumorsL E Holm, G Eklund, G Lundell
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Second primary tumors following thyroid cancer. A Swedish record-linkage studyP Hall, L E Holm, G Lundell
Lakartidningen|November 11, 1992
[Follow the ALARA principle]G Lundell, P Hall, L E Holm
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Cancer|January 1, 1997
Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinomaA Taube, G Lundell
Lakartidningen|September 19, 1973
[A new system of dose-portion administration of drugs]G Lundell, L Nilsson
Acta Radiologica. Oncology|January 1, 1980
Hypothyroidism following 131I therapy for hyperthyroidism in relation to immunologic parametersG Lundell, L E Holm
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1989
Swedish thyroid cancer risk from Chernobyl?L E Holm, G Lundell
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|January 22, 2005
Anaplastic giant cell thyroid carcinomaG Wallin, G Lundell, J Tennvall
Acta Endocrinologica|August 1, 1993
Graves' ophthalmopathy and tobacco smokingL Tallstedt, G Lundell, A Taube
Acta Radiologica: Therapy, Physics, Biology|May 1, 1977
75Se-Selenite scrintigraphy in the clinical staging of malignant lymphomasD Killander, D Lindblom, G Lundell
Journal of the National Cancer Institute|December 1, 1980
Incidence of malignant thyroid tumors in humans after exposure to diagnostic doses of iodine-131. II. Estimation of thyroid gland size, thyroid radiation dose, and predicted versus observed number of malignant thyroid tumorsL E Holm, G Eklund, G Lundell
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Second primary tumors following thyroid cancer. A Swedish record-linkage studyP Hall, L E Holm, G Lundell
Lakartidningen|November 11, 1992
[Follow the ALARA principle]G Lundell, P Hall, L E Holm
Pageof 11